Published on September 21, 2017
When is immuotherapy an option for lung cancer patients with genetic mutations? Dr. Frank Griesinger, lung cancer specialist and Head of Clinical Oncology at Pius-Hospital (Oldenburg, Germany) gives an update on alternative options for these patients.
This interview was recorded at the European Society of Medical Oncology (ESMO) congress held in Madrid (September 2017). Lung cancer videos recorded at ESMO 17 are part of an educational program by the Patient Empowerment Foundation (PEF). We thank AstraZeneca for their support.